MINUTES
About Minutes
Back to latest

HealthAmgen says Sjogren’s drug cuts disease activity in trial

Amgen said on Wednesday that detailed data from a late-stage trial showed its experimental Sjogren’s disease drug significantly reduced disease activity in patients.

AmgenSjogren’s diseaseclinical trial

RReuters★★☆☆☆2026-11-11 17:05Original

Amgen says Sjogren’s drug cuts disease activity in trial
Amgen says Sjogren’s drug cuts disease activity in trialHealth